Sven Hoffmeyer
- Oncology top 1%
- Drug Transport and Resistance Mechanisms 5
- Pharmacology top 0.2%
- Transplantation top 2%
-
- Pharmacological Effects and Toxicity Studies 2
- Neurology top 5%
- Neurofibromatosis and Schwannoma Cases 14
-
- Sarcoma Diagnosis and Treatment 6
-
- Soft tissue tumor case studies 4
-
- Hippo pathway signaling and YAP/TAZ 3
-
- Chromatin Remodeling and Cancer 3
-
- Meningioma and schwannoma management 2
- Co-authors
- Ulrich BrinkmannIngolf CascorbiIvar RootsAndreas JohneThomas GerloffOliver BurkMichel EichelbaumOliver von Richter
- Cited by
- OncologyPharmacologyTransplantation
- Journals
- The American Journal of Human Genetics (2 papers)Archives of Dermatological Research (2 papers)Human Genetics (2 papers)
- Partner nations
- GermanyUnited StatesIran
In The Last Decade
Sven Hoffmeyer
19 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Oncology 2.4k
- Pharmacology 736
- Transplantation 216
- Pediatrics, Perinatology and Child Health 1.5k
- Neurology 392
Countries citing papers authored by Sven Hoffmeyer
This map shows the geographic impact of Sven Hoffmeyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sven Hoffmeyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sven Hoffmeyer more than expected).
Fields of papers citing papers by Sven Hoffmeyer
This network shows the impact of papers produced by Sven Hoffmeyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sven Hoffmeyer. The network helps show where Sven Hoffmeyer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sven Hoffmeyer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 210 | |
| 2 | 2002 | 267 | |
| 3 | Aberrant splicing in several human tumors in the tumor suppressor genes neurofibromatosis type 1, neurofibromatosis type 2, and tuberous sclerosis 2. | 2002 | 30 |
| 4 | 2001 | 157 | |
| 5 | 2000 | 231 | |
| 6 | Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivobreakdown → | 2000 | 1951 |
| 7 | 2000 | 470 | |
| 8 | 1999 | 18 | |
| 9 | 1999 | 22 | |
| 10 | 1999 | 6 | |
| 11 | 1999 | 9 | |
| 12 | 1999 | 2 | |
| 13 | 1998 | 45 | |
| 14 | 1997 | 49 | |
| 15 | 1995 | 40 | |
| 16 | 1995 | 3 | |
| 17 | 1994 | 11 | |
| 18 | 1994 | 36 | |
| 19 | 1994 | 28 |
About Sven Hoffmeyer
Sven Hoffmeyer is a scholar working on Neurology, Rheumatology and Ophthalmology, having authored 19 papers that have together received 3.6k indexed citations. Recurring topics across this work include Neurofibromatosis and Schwannoma Cases (14 papers), Sarcoma Diagnosis and Treatment (6 papers), Drug Transport and Resistance Mechanisms (5 papers), Soft tissue tumor case studies (4 papers), Hippo pathway signaling and YAP/TAZ (3 papers), Chromatin Remodeling and Cancer (3 papers), Pharmacological Effects and Toxicity Studies (2 papers) and Meningioma and schwannoma management (2 papers). The work is most often cited by research in Oncology (2.4k citations), Pharmacology (736 citations) and Transplantation (216 citations). Sven Hoffmeyer has collaborated with scholars based in Germany, United States and Iran. Frequent co-authors include Ulrich Brinkmann, Ingolf Cascorbi, Ivar Roots, Andreas Johne, Thomas Gerloff, Oliver Burk, Michel Eichelbaum, Oliver von Richter, J. Brockmöller and Reinhold Kerb. Their work appears in journals such as The American Journal of Human Genetics, Archives of Dermatological Research, Human Genetics, Proceedings of the National Academy of Sciences and Pharmacogenomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.